Author: Jane Edwards|| Date Published: February 28, 2022
The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for the proposed acquisition of health information technology company Cerner (Nasdaq: CERN) by Oracle (NYSE: ORCL) expired Tuesday, Feb. 22.
Oracle agreed to acquire Cerner for approximately $28.3 billion through an all-cash tender offer in late December and both parties expect the tender offer to expire on March 16, Oracle said Wednesday.
The tender offer of $95 a share for Cerner stock was originally scheduled to expire on Feb. 15, but Oracle announced on Feb. 11 that it extended the offer’s expiration by a month.
The two companies may further extend the tender offer to provide more time to satisfy the remaining conditions, including clearances under foreign direct investment laws and foreign competition laws.
Elsevier highlights growing impact of geopolitical tensions on research Governments face tension between security priorities and open science goals AI…
Deltek’s 2026 GovCon Clarity Report found contractors accelerating operations and AI adoption while struggling to maintain profitability and control. Kevin…
Quiet Professionals, Spathe Systems rebrand as Endurion. New platform combines intelligence, operations and mission technology support. Endurion launches following recent…
John Roese, global chief technology officer and chief artificial intelligence officer at Dell Technologies, said government agencies seeking to advance…
Stockholders of semiconductor foundry SkyWater Technology have approved the company’s merger with quantum computing company IonQ. Quantum computing and post-quantum…
